RUNX1/RUNX1T1 t (8;21) gene fusion probe, AML1/ETO (CE-IVD)
Catalog No : FP-044
513.00€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | RUNX1/RUNX1T1 t (8;21) gene fusion probe, AML1/ETO (CE-IVD) | ||
|---|---|---|---|
| Catalog No | FP-044 | ||
| Supplier’s Catalog No | FP-044 | ||
| Supplier | Wuhan Healthcare Biotech | ||
| Source antigen | AML1 | ||
| Reactivity | AML1 | ||
| Cross reactivity | None | ||
| Applications | Fluorescence In Situ Hybridization (FISH) | ||
| Molecular weight | N/A | ||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Molecular diagnostic grade | ||
| Purity | N/A | ||
| Form | Liquid | ||
| Reactivity life | 12 months when stored properly according to instructions | ||
| Note | For Professional In Vitro diagnostics | ||
| Description | The AML1/ETO gene fusion can be used as a secondary diagnosis of AML and a means of assessing prognosis. Clinically, t(8;21) leukemia represents a type of acute leukemia with good prognosis. Adult patients have good response to treatment, high complete remission rate, long median survival time, but easy recurrence; children's treatment and prognosis are not as good as adult patients. | ||
Product Details
© 2020 Imugex All Rights Reserved